Although an increasing development of resistance to permethrin has been reported in recent years, this topical therapeutic agent is still the first choice for the treatment of common scabies due to its favorable side effect profile. If the prescribed use of permethrin in combination with ivermectin does not lead to healing, alternative treatment options can be used. This approach has proved successful at Zurich Children’s Hospital to date.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Compression
Lymphoedema and chronic wounds
- Epilepsy
The treatment of refractory status epilepticus – an overview
- Podiatry support to improve quality of life
Patient mobility with a foot wound
- Rare diseases
Cogan syndrome – a clinical challenge
- Polymyalgia rheumatica and giant cell arteritis
New consensus paper recommends “treat-to-target” strategy
- Threat from Aedes mosquitoes
Dengue, Zika and Chikungunya viruses on the rise
- Systemic lupus erythematosus
DORIS and LLDAS are also worthwhile for severe cases
- Malnutrition in old age